Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome

NCT05510596 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05510596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05510596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
September 22, 2022
Completion date
September 14, 2023
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, b-cell, neurotoxicity